Cargando…
Novel Anti-Acanthamoebic Activities of Irosustat and STX140 and Their Nanoformulations
Pathogenic Acanthamoeba produce keratitis and fatal granulomatous amoebic encephalitis. Treatment remains problematic and often ineffective, suggesting the need for the discovery of novel compounds. For the first time, here we evaluated the effects of the anticancer drugs Irosustat and STX140 alone,...
Autores principales: | Siddiqui, Ruqaiyyah, Rawas-Qalaji, Mutasem, El-Gamal, Mohammed I., Sajeev, Sreedevi, Jagal, Jayalakshmi, Zaraei, Seyed-Omar, Sbenati, Rawan M., Anbar, Hanan S., Dohle, Wolfgang, Potter, Barry V. L., Khan, Naveed Ahmed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044433/ https://www.ncbi.nlm.nih.gov/pubmed/36978428 http://dx.doi.org/10.3390/antibiotics12030561 |
Ejemplares similares
-
Pharmaceutical equivalency of locally and regionally manufactured generic pharmaceutical products in UAE
por: Al Ali, Lamia, et al.
Publicado: (2022) -
Formulation and optimization of ivermectin nanocrystals for enhanced topical delivery
por: Awad, Hoda, et al.
Publicado: (2023) -
Structure–Activity Relationship for the First-in-Class Clinical Steroid Sulfatase Inhibitor Irosustat (STX64, BN83495)
por: Woo, L W Lawrence, et al.
Publicado: (2011) -
Epinephrine in Anaphylaxis: Preclinical Study of Pharmacokinetics after Sublingual Administration of Taste-Masked Tablets for Potential Pediatric Use
por: Rachid, Ousama, et al.
Publicado: (2018) -
Successful management of post-COVID-19 acanthamoebic encephalitis
por: Siripurapu, Govinda, et al.
Publicado: (2021)